Abstract
The aim of this paper is based on the use of a hyaluronic acid hydrogel of Quercetin tested alone and in combination to an inhibitor of Aurora Kinase type A and B (SNS-314) on human medullary and papillary thyroid cancer cells. Biological investigations were focused on the cellular uptake of the hydrogel, cell viability, antioxidant, and cytokines secretion studies. Quercetin delivered from hydrogel show a time and CD44 dependent interaction with both cell lines with significant anti-inflammatory effects. Combination of Quercetin and SNS-314 leads to a synergistic cytotoxic effect on medullary TT and papillary BCPAP cell lines with a significant reduction of the IC50 value. These results, highlights the importance of synergistic effect of the hyaluronic acid hydrogel of Quercetin with SNS-314 in the regulation of human thyroid cancer cell proliferation and emphasize the anti-tumor activity of these molecules. J. Cell. Physiol. 231: 1784-1795, 2016. © 2015 Wiley Periodicals, Inc.
© 2015 Wiley Periodicals, Inc.
MeSH terms
-
Anti-Inflammatory Agents / pharmacology
-
Antineoplastic Combined Chemotherapy Protocols / chemistry
-
Antineoplastic Combined Chemotherapy Protocols / metabolism
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology*
-
Antioxidants / metabolism
-
Aurora Kinase A / genetics
-
Aurora Kinase A / metabolism*
-
Aurora Kinase B / antagonists & inhibitors*
-
Aurora Kinase B / metabolism
-
Carcinoma / drug therapy*
-
Carcinoma / enzymology
-
Carcinoma / pathology
-
Carcinoma, Neuroendocrine / drug therapy*
-
Carcinoma, Neuroendocrine / enzymology
-
Carcinoma, Neuroendocrine / pathology
-
Carcinoma, Papillary
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Cell Survival / drug effects
-
Chemistry, Pharmaceutical
-
Cytokines / metabolism
-
Dose-Response Relationship, Drug
-
Drug Carriers*
-
Drug Synergism
-
Humans
-
Hyaluronan Receptors / metabolism
-
Hyaluronic Acid / chemistry*
-
Hydrogels
-
Inhibitory Concentration 50
-
Phenylurea Compounds / chemistry
-
Phenylurea Compounds / metabolism
-
Phenylurea Compounds / pharmacology*
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / metabolism
-
Protein Kinase Inhibitors / pharmacology*
-
Quercetin / chemistry
-
Quercetin / metabolism
-
Quercetin / pharmacology*
-
Thiazoles / chemistry
-
Thiazoles / metabolism
-
Thiazoles / pharmacology*
-
Thyroid Cancer, Papillary
-
Thyroid Neoplasms / drug therapy*
-
Thyroid Neoplasms / enzymology
-
Thyroid Neoplasms / pathology
-
Time Factors
Substances
-
Anti-Inflammatory Agents
-
Antioxidants
-
CD44 protein, human
-
Cytokines
-
Drug Carriers
-
Hyaluronan Receptors
-
Hydrogels
-
Phenylurea Compounds
-
Protein Kinase Inhibitors
-
SNS 314
-
Thiazoles
-
Hyaluronic Acid
-
Quercetin
-
AURKA protein, human
-
AURKB protein, human
-
Aurora Kinase A
-
Aurora Kinase B
Supplementary concepts
-
Thyroid cancer, medullary